$EBS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Emergent BioSolutions Inc.. Get notifications about new insider transactions in Emergent BioSolutions Inc. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 21 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,036 | 0 | 36,118 | 31.1 K to 36.1 K (+16.20 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,036 | 0 | 31,082 | 26 K to 31.1 K (+19.34 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Option Exercise | A | 49.64 | 21,253 | 1,054,999 | 21,253 | |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,313 | 0 | 23,440 | 18.1 K to 23.4 K (+29.31 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,313 | 0 | 18,127 | 12.8 K to 18.1 K (+41.46 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Option Exercise | A | 49.64 | 16,116 | 799,998 | 16,116 | |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 49.97 | 540 | 26,984 | 17,071 | 17.6 K to 17.1 K (-3.07 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 49.64 | 387 | 19,211 | 17,611 | 18 K to 17.6 K (-2.15 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 4,029 | 0 | 17,998 | 14 K to 18 K (+28.84 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 4,029 | 0 | 13,969 | 9.9 K to 14 K (+40.53 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Option Exercise | A | 49.64 | 23,670 | 1,174,979 | 23,670 | |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Payment of Exercise | F | 49.97 | 1,545 | 77,204 | 91,606 | 93.2 K to 91.6 K (-1.66 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Payment of Exercise | F | 49.64 | 778 | 38,620 | 93,151 | 93.9 K to 93.2 K (-0.83 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Grant | A | 0.00 | 5,917 | 0 | 93,929 | 88 K to 93.9 K (+6.72 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Grant | A | 0.00 | 5,917 | 0 | 88,012 | 82.1 K to 88 K (+7.21 %) |
| Jan 24 2018 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Option Exercise | M | 25.47 | 5,152 | 131,221 | 0 | |
| Jan 24 2018 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 50.25 | 2,577 | 129,494 | 16,068 | 18.6 K to 16.1 K (-13.82 %) |
| Jan 24 2018 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 50.91 | 5,152 | 262,292 | 18,645 | 23.8 K to 18.6 K (-21.65 %) |
| Jan 24 2018 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Buy | M | 25.47 | 5,152 | 131,221 | 23,797 | 18.6 K to 23.8 K (+27.63 %) |
| Jan 04 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 14.44 | 21,906 | 316,323 | 0 | |
| Jan 04 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 47.91 | 21,906 | 1,049,516 | 204,134 | 226 K to 204.1 K (-9.69 %) |
| Jan 04 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 14.44 | 21,906 | 316,323 | 226,040 | 204.1 K to 226 K (+10.73 %) |
| Dec 14 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 14.44 | 20,000 | 288,800 | 21,906 | |
| Dec 14 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 45.99 | 20,000 | 919,800 | 204,134 | 224.1 K to 204.1 K (-8.92 %) |
| Dec 14 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 14.44 | 20,000 | 288,800 | 224,134 | 204.1 K to 224.1 K (+9.80 %) |
| Dec 13 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 10.64 | 23,681 | 251,966 | 0 | |
| Dec 13 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 45.02 | 23,681 | 1,066,225 | 23,410 | 47.1 K to 23.4 K (-50.29 %) |
| Dec 13 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 10.64 | 23,681 | 251,966 | 47,091 | 23.4 K to 47.1 K (+101.16 %) |
| Dec 11 2017 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 42.47 | 7,000 | 297,290 | 37,077 | 44.1 K to 37.1 K (-15.88 %) |
| Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 22.03 | 27,983 | 616,465 | 0 | |
| Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 22.03 | 20,000 | 440,600 | 27,983 | |
| Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 42.08 | 27,983 | 1,177,525 | 1,530,216 | 1.6 M to 1.5 M (-1.80 %) |
| Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 22.03 | 27,983 | 616,465 | 1,558,199 | 1.5 M to 1.6 M (+1.83 %) |
| Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 41.59 | 20,000 | 831,800 | 1,530,216 | 1.6 M to 1.5 M (-1.29 %) |
| Nov 30 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 22.03 | 20,000 | 440,600 | 1,550,216 | 1.5 M to 1.6 M (+1.31 %) |
| Nov 15 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 40.05 | 20,000 | 801,000 | 1,490,216 | 1.5 M to 1.5 M (-1.32 %) |
| Nov 15 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 40.69 | 20,000 | 813,800 | 1,510,216 | 1.5 M to 1.5 M (-1.31 %) |
| Nov 09 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Option Exercise | M | 18.64 | 10,305 | 192,085 | 0 | |
| Nov 09 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Option Exercise | M | 15.97 | 3,946 | 63,018 | 0 | |
| Nov 09 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Sell | S | 41.24 | 10,305 | 424,978 | 30,377 | 40.7 K to 30.4 K (-25.33 %) |
| Nov 09 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Buy | M | 18.64 | 10,305 | 192,085 | 40,682 | 30.4 K to 40.7 K (+33.92 %) |
| Nov 09 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Sell | S | 41.24 | 3,946 | 162,733 | 30,377 | 34.3 K to 30.4 K (-11.50 %) |
| Nov 09 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Buy | M | 15.97 | 3,946 | 63,018 | 34,323 | 30.4 K to 34.3 K (+12.99 %) |
| Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 14.44 | 20,000 | 288,800 | 41,906 | |
| Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 22.03 | 11,508 | 253,521 | 0 | |
| Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 42.92 | 20,000 | 858,400 | 204,134 | 224.1 K to 204.1 K (-8.92 %) |
| Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 14.44 | 20,000 | 288,800 | 224,134 | 204.1 K to 224.1 K (+9.80 %) |
| Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 42.50 | 11,508 | 489,090 | 204,134 | 215.6 K to 204.1 K (-5.34 %) |
| Nov 07 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 22.03 | 11,508 | 253,521 | 215,642 | 204.1 K to 215.6 K (+5.64 %) |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 7.99 | 22,415 | 179,096 | 0 | |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 7.99 | 1,266 | 10,115 | 22,415 | |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 40.00 | 22,415 | 896,600 | 23,410 | 45.8 K to 23.4 K (-48.91 %) |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 7.99 | 22,415 | 179,096 | 45,825 | 23.4 K to 45.8 K (+95.75 %) |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 40.00 | 1,266 | 50,640 | 23,410 | 24.7 K to 23.4 K (-5.13 %) |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 7.99 | 1,266 | 10,115 | 24,676 | 23.4 K to 24.7 K (+5.41 %) |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 40.50 | 25,000 | 1,012,500 | 1,530,216 | 1.6 M to 1.5 M (-1.61 %) |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 39.50 | 25,000 | 987,500 | 1,555,216 | 1.6 M to 1.6 M (-1.58 %) |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | M | 22.03 | 7,885 | 173,707 | 0 | |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 39.50 | 7,885 | 311,458 | 26,046 | 33.9 K to 26 K (-23.24 %) |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 22.03 | 7,885 | 173,707 | 33,931 | 26 K to 33.9 K (+30.27 %) |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 22.03 | 15,000 | 330,450 | 11,508 | |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 39.92 | 15,000 | 598,770 | 204,134 | 219.1 K to 204.1 K (-6.85 %) |
| Sep 29 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 22.03 | 15,000 | 330,450 | 219,134 | 204.1 K to 219.1 K (+7.35 %) |
| Sep 14 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 38.50 | 23,547 | 906,560 | 1,580,216 | 1.6 M to 1.6 M (-1.47 %) |
| Sep 14 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 38.50 | 1,453 | 55,941 | 1,603,763 | 1.6 M to 1.6 M (-0.09 %) |
| Sep 12 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | M | 22.03 | 7,885 | 173,707 | 7,885 | |
| Sep 12 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 37.06 | 7,885 | 292,243 | 26,046 | 33.9 K to 26 K (-23.24 %) |
| Sep 12 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 22.03 | 7,885 | 173,707 | 33,931 | 26 K to 33.9 K (+30.27 %) |
| Sep 08 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 37.50 | 16,439 | 616,463 | 1,605,216 | 1.6 M to 1.6 M (-1.01 %) |
| Sep 06 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 37.50 | 3,100 | 116,250 | 1,621,655 | 1.6 M to 1.6 M (-0.19 %) |
| Sep 05 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 22.03 | 15,000 | 330,450 | 26,508 | |
| Sep 05 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 37.21 | 15,000 | 558,150 | 204,134 | 219.1 K to 204.1 K (-6.85 %) |
| Sep 05 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 22.03 | 15,000 | 330,450 | 219,134 | 204.1 K to 219.1 K (+7.35 %) |
| Sep 01 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 37.50 | 5,461 | 204,788 | 1,624,755 | 1.6 M to 1.6 M (-0.33 %) |
| Aug 17 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Option Exercise | M | 25.47 | 5,153 | 131,247 | 5,152 | |
| Aug 17 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 35.83 | 10,776 | 386,149 | 18,645 | 29.4 K to 18.6 K (-36.63 %) |
| Aug 17 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Grant | A | 25.47 | 5,153 | 131,247 | 29,421 | 24.3 K to 29.4 K (+21.23 %) |
| Aug 10 2017 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Option Exercise | A | 36.09 | 20,083 | 724,795 | 20,083 | |
| Aug 10 2017 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 12,814 | 0 | 12,814 | 0 to 12.8 K |
| Jul 28 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 36.50 | 25,000 | 912,500 | 1,630,216 | 1.7 M to 1.6 M (-1.51 %) |
| Jul 21 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 35.50 | 25,000 | 887,500 | 1,655,216 | 1.7 M to 1.7 M (-1.49 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Option Exercise | J | 18.64 | 301 | 5,611 | 3,434 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Grant | A | 0.00 | 8,259 | 0 | 44,077 | 35.8 K to 44.1 K (+23.06 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Buy | J | 0.00 | 577 | 0 | 35,818 | 35.2 K to 35.8 K (+1.64 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Buy | J | 0.00 | 604 | 0 | 35,241 | 34.6 K to 35.2 K (+1.74 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Buy | J | 0.00 | 152 | 0 | 34,637 | 34.5 K to 34.6 K (+0.44 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Grant | A | 0.00 | 8,259 | 0 | 24,268 | 16 K to 24.3 K (+51.59 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Grant | A | 0.00 | 8,259 | 0 | 22,485 | 14.2 K to 22.5 K (+58.06 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Grant | A | 0.00 | 8,259 | 0 | 44,077 | 35.8 K to 44.1 K (+23.06 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | J | 18.64 | 905 | 16,869 | 10,305 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | J | 13.00 | 693 | 9,009 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | J | 13.37 | 693 | 9,265 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | J | 20.08 | 693 | 13,915 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | J | 14.71 | 693 | 10,194 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | J | 10.64 | 2,081 | 22,142 | 23,681 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | J | 7.99 | 2,081 | 16,627 | 23,681 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Grant | A | 0.00 | 8,259 | 0 | 23,410 | 15.2 K to 23.4 K (+54.51 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 18.64 | 905 | 16,869 | 10,305 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 13.00 | 693 | 9,009 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 13.37 | 693 | 9,265 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 20.08 | 693 | 13,915 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 14.71 | 693 | 10,194 | 7,893 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 8,259 | 0 | 40,077 | 31.8 K to 40.1 K (+25.96 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | J | 0.00 | 577 | 0 | 35,818 | 35.2 K to 35.8 K (+1.64 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | J | 0.00 | 604 | 0 | 35,241 | 34.6 K to 35.2 K (+1.74 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | J | 0.00 | 152 | 0 | 34,637 | 34.5 K to 34.6 K (+0.44 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Option Exercise | J | 18.64 | 905 | 16,869 | 10,305 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Option Exercise | J | 15.97 | 346 | 5,526 | 3,946 | |
| May 26 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Grant | A | 0.00 | 8,259 | 0 | 30,377 | 22.1 K to 30.4 K (+37.34 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Buy | J | 0.00 | 577 | 0 | 22,118 | 21.5 K to 22.1 K (+2.68 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Buy | J | 0.00 | 604 | 0 | 21,541 | 20.9 K to 21.5 K (+2.88 %) |
| May 26 2017 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Buy | J | 0.00 | 152 | 0 | 20,937 | 20.8 K to 20.9 K (+0.73 %) |
| Apr 04 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 28.62 | 11,419 | 326,808 | 26,046 | 37.5 K to 26 K (-30.48 %) |
| Mar 16 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Gift | G | 0.00 | 1,800 | 0 | 37,465 | 39.3 K to 37.5 K (-4.58 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 31.05 | 1,624 | 50,425 | 39,265 | 40.9 K to 39.3 K (-3.97 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 30.98 | 1,076 | 33,334 | 40,889 | 42 K to 40.9 K (-2.56 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Payment of Exercise | F | 31.05 | 3,007 | 93,367 | 82,095 | 85.1 K to 82.1 K (-3.53 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Payment of Exercise | F | 30.98 | 1,908 | 59,110 | 85,102 | 87 K to 85.1 K (-2.19 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 31.05 | 10,738 | 333,415 | 204,134 | 214.9 K to 204.1 K (-5.00 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 30.98 | 8,226 | 254,841 | 214,872 | 223.1 K to 214.9 K (-3.69 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 20,554 | 0 | 62,064 | |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 13,236 | 0 | 82,618 | |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 31.05 | 6,089 | 189,063 | 1,680,216 | 1.7 M to 1.7 M (-0.36 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 20,554 | 0 | 1,686,305 | 1.7 M to 1.7 M (+1.23 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 30.98 | 3,621 | 112,179 | 1,665,751 | 1.7 M to 1.7 M (-0.22 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 13,236 | 0 | 1,669,372 | 1.7 M to 1.7 M (+0.80 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Option Exercise | J | 25.47 | 905 | 23,050 | 10,305 | |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 31.27 | 2,576 | 80,558 | 16,009 | 18.6 K to 16 K (-13.86 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Buy | J | 0.00 | 577 | 0 | 18,585 | 18 K to 18.6 K (+3.20 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Buy | J | 0.00 | 604 | 0 | 18,008 | 17.4 K to 18 K (+3.47 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Buy | J | 0.00 | 453 | 0 | 17,404 | 17 K to 17.4 K (+2.67 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 30.63 | 58,747 | 1,799,421 | 58,747 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,722 | 0 | 95,854 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 29,382 | 0 | 105,576 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 30.63 | 2,659 | 81,445 | 1,656,136 | 1.7 M to 1.7 M (-0.16 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,722 | 0 | 1,658,795 | 1.6 M to 1.7 M (+0.59 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Option Exercise | A | 30.63 | 32,638 | 999,702 | 32,638 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Option Exercise | J | 30.86 | 2,847 | 87,858 | 32,397 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Option Exercise | J | 26.45 | 2,121 | 56,100 | 24,132 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Option Exercise | J | 25.62 | 1,672 | 42,837 | 19,026 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Payment of Exercise | F | 30.63 | 1,799 | 55,103 | 87,010 | 88.8 K to 87 K (-2.03 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Grant | A | 0.00 | 8,162 | 0 | 88,809 | 80.6 K to 88.8 K (+10.12 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Grant | A | 0.00 | 8,161 | 0 | 80,647 | 72.5 K to 80.6 K (+11.26 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Buy | J | 0.00 | 1,425 | 0 | 72,486 | 71.1 K to 72.5 K (+2.01 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Buy | J | 0.00 | 1,061 | 0 | 71,061 | 70 K to 71.1 K (+1.52 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Buy | J | 0.00 | 1,672 | 0 | 70,000 | 68.3 K to 70 K (+2.45 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | A | 30.63 | 17,134 | 524,814 | 17,134 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 30.63 | 938 | 28,731 | 41,965 | 42.9 K to 42 K (-2.19 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Grant | A | 0.00 | 4,285 | 0 | 42,903 | 38.6 K to 42.9 K (+11.10 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Grant | A | 0.00 | 4,285 | 0 | 38,618 | 34.3 K to 38.6 K (+12.48 %) |